The FDA approved tavapadon, a new Parkinson’s drug sold under the brand name Juvmo, on September 25, 2026. This once-daily medication helps manage movement symptoms such as tremors, stiffness, and slowed movement.
Clinical trials demonstrated improvements in movement and daily functioning, offering another treatment option for individuals living with Parkinson’s disease.
While tavapadon is not a cure, its approval represents encouraging progress for individuals and families seeking better symptom management.
Key Takeaways
- New FDA-approved medication: Tavapadon (Juvmo) is a once-daily oral treatment for adults living with Parkinson’s disease.
- Improved movement and daily functioning: Clinical trials showed benefits for individuals with both earlier and progressing Parkinson’s.
- More time with controlled symptoms: When combined with levodopa, tavapadon provided approximately one additional hour of daily symptom control without troublesome involuntary movements, compared with placebo.
- Personalized treatment remains essential: Families should discuss potential benefits, side effects, and individual care needs with a neurologist.
Tavapadon vs. Levodopa: What Is the Difference?
Both medications help manage Parkinson’s movement symptoms, but they work differently.
| Tavapadon (Juvmo) | Levodopa |
| Activates specific dopamine receptors in the brain | Converts into dopamine in the brain |
| Taken once daily | Dosing schedules vary |
| Can be used alone or with levodopa | Often used as a foundational Parkinson’s treatment |
| FDA-approved in September 2026 | Established treatment used for decades |
Tavapadon does not necessarily replace levodopa. For some individuals, the medications may be prescribed together to improve symptom control.
At The Kensington Sierra Madre, we understand how Parkinson’s can affect daily routines and independence. Our personalized approach helps residents receive the support they need as their circumstances change.
Explore Parkinson’s care at The Kensington Sierra Madre and discover how we can support your loved one.
How Parkinson’s Disease Affects Dopamine Levels and Movement
Parkinson’s disease is a progressive neurological condition that affects movement and coordination. It develops as nerve cells that produce dopamine gradually become damaged or die.
Dopamine is a brain chemical that helps regulate smooth, controlled movement.
As dopamine levels decrease, individuals may experience:
- Tremors in the hands, arms, or legs
- Muscle stiffness or rigidity
- Slower movements
- Changes in walking and balance
- Difficulty completing everyday activities
According to The Michael J. Fox Foundation, tavapadon belongs to a class of Parkinson’s medications called dopamine agonists.
These medications work by stimulating dopamine receptors in the brain, helping compensate for reduced dopamine activity and improve movement-related symptoms.
How Does Tavapadon Work?
Unlike treatments that increase dopamine levels, tavapadon works by activating specific dopamine receptors in the brain. This helps improve motor function in people living with Parkinson’s disease.
The key differences in tavapadon include:
- Targeted receptors: Tavapadon selectively activates D1 and D5 receptors, which help regulate movement.
- Different mechanism: Older dopamine agonists primarily target other receptors involved in movement, alertness, and reward-related behaviors.
- Potential safety advantages: Tavapadon’s selective approach may reduce certain side effects, although direct comparisons with older dopamine agonists have not established this.
This targeted approach distinguishes tavapadon from existing dopamine agonists, although more research is needed to understand its long-term benefits and risks.
For families learning about Parkinson’s, our guide to the early signs of Parkinson’s disease offers additional information.
What Benefits Did the Tavapadon Clinical Trials Show?
The FDA approval was supported by the TEMPO clinical trial program, which evaluated tavapadon in individuals at different stages of Parkinson’s disease.
Results showed improvements in movement symptoms and daily functioning.
Benefits for Individuals With Earlier Parkinson’s
The TEMPO-1 and TEMPO-2 studies examined tavapadon in individuals diagnosed within the previous three years who were not taking dopamine medications.
Compared with placebo, participants taking tavapadon experienced improvements in motor symptoms and everyday activities.
These included tasks such as:
- Getting dressed
- Eating meals
- Managing personal hygiene
- Completing movements that require coordination
For someone living with Parkinson’s, seemingly small improvements can be meaningful.
Buttoning a shirt, using utensils, or preparing for the day may become more manageable when symptoms are better controlled.
However, individual responses vary, and the benefits of medication must be weighed against potential side effects.
Benefits for Individuals With Progressing Parkinson’s
The TEMPO-3 trial studied individuals taking levodopa who experienced fluctuations in symptom control.
These fluctuations are commonly described as:
- On time: Periods when medication is working well, and movement symptoms are better controlled.
- Off time: Periods when medication effects diminish and symptoms such as tremors, stiffness, or slowed movement return.
What Did the TEMPO-3 Trial Find?
Compared with adding placebo, adding tavapadon to levodopa resulted in:
- Approximately one additional hour of daily on time without troublesome dyskinesia, which refers to involuntary movements that can develop during Parkinson’s treatment.
- Approximately 1 additional hour of daily off time, reducing the periods when symptoms return between medication doses.
These results highlight tavapadon’s potential to help individuals experiencing fluctuations in symptom control while taking levodopa.
The clinical results are detailed in The Michael J. Fox Foundation’s September 2026 approval report.
What Are the Side Effects and Risks of Tavapadon?
Although tavapadon offers encouraging benefits, families should understand its potential risks before considering treatment changes.
According to AbbVie’s FDA approval announcement, commonly reported side effects included:
- Nausea
- Headaches
- Dizziness
- Fatigue
- Changes in taste
- Vomiting or dry mouth
Some side effects were more commonly reported among individuals taking tavapadon alongside levodopa, including dyskinesia, hallucinations, and orthostatic hypotension.
Why Should Older Adults Be Especially Careful?
Certain tavapadon side effects may present additional safety concerns for older adults, particularly those experiencing mobility or balance challenges.
Potential concerns include:
- Increased fall risk: Dizziness and orthostatic hypotension, a drop in blood pressure when standing, can make walking and changing positions less safe.
- Changes in perception: Hallucinations may cause confusion or distress, particularly for individuals already experiencing cognitive changes.
- Reduced alertness: Sudden sleepiness can create safety concerns during walking, eating, or other daily activities.
- Behavioral changes: Impulse control difficulties may lead to unusual spending, eating, or other hard-to-resist behaviors.
What Is Still Being Studied?
Researchers continue to evaluate tavapadon’s long-term safety through the TEMPO-4 extension study.
While the initial clinical trials provide encouraging findings, longer-term research will help clarify its safety profile and potential risks.
What Should Families Ask Their Loved One’s Neurologist?
New Parkinson’s treatments can bring hope, particularly when a loved one’s current medication is no longer providing consistent relief.
However, the newest medication is not automatically the best choice for everyone.
Before discussing tavapadon, consider preparing these questions for your loved one’s neurologist.
Ask the Doctor About Tavapadon
- Is tavapadon appropriate for my loved one? Discuss their current symptoms, disease progression, and treatment history.
- Can it be taken with existing medications? Review all prescriptions, supplements, and over-the-counter medications.
- What improvements might we realistically expect? Ask which movement symptoms may respond and how benefits will be evaluated.
- Which side effects require attention? Discuss dizziness, hallucinations, excessive sleepiness, and behavioral changes.
- How will treatment progress be monitored? Ask about follow-up visits, symptom tracking, and when to report changes.
Keep Track of Symptoms Between Appointments
A simple daily journal can provide useful information for medical appointments.
Consider recording:
- When tremors or stiffness become more noticeable
- Times when movement is easier or more difficult
- Changes in sleep, mood, or alertness
- Difficulties with dressing, eating, or walking
- New symptoms following medication adjustments
These details may help clinicians identify patterns and evaluate treatment effectiveness.
Never change Parkinson’s medications or dosing schedules without guidance from the prescribing clinician.
Families should also remember that Parkinson’s affects more than movement. Our article on non-motor symptoms of Parkinson’s disease explores changes involving sleep, mood, digestion, and cognition.
How Can Personalized Care Support Someone Living With Parkinson’s?
Medication can help manage Parkinson’s symptoms, but it is only one part of maintaining quality of life.
As the condition progresses, some individuals require more assistance with mobility, personal care, medication routines, or everyday tasks.
Families may notice their loved one:
- Taking longer to get dressed or prepare meals
- Experiencing difficulty standing or walking
- Needing help remembering medication schedules
- Becoming less confident moving around independently
- Requiring additional assistance with personal hygiene
These changes do not automatically mean assisted living is necessary. However, they may indicate that it is time to reassess the level of support available at home.
The Importance of Consistent Daily Support
A personalized Parkinson’s care plan may include assistance with several important needs.
- Medication management: Helping individuals adhere to prescribed medication regimens and coordinating concerns with medical professionals.
- Mobility and personal care: Providing appropriate help with walking, transfers, bathing, dressing, and other daily activities.
- Rehabilitation services: Supporting access to physical, occupational, or speech therapy when recommended.
- Social connection: Encouraging participation in meaningful activities that reflect individual interests and abilities.
At The Kensington Sierra Madre, our assisted living services are designed to provide individualized assistance while helping residents maintain as much independence as possible.
The Kensington Difference
Our community offers:
- Licensed nurses on-site 24 hours a day
- Medication administration by licensed nurses and medication technicians
- Assistance with dressing, bathing, and other personal care needs
- On-site physical therapy and access to rehabilitation services
- Life enrichment opportunities and social engagement
These services can be especially valuable when Parkinson’s symptoms begin affecting daily routines.
Our team members also work with families and medical providers to support care plans as residents’ needs change.
Compassionate Parkinson’s Support at The Kensington Sierra Madre
At The Kensington Sierra Madre, compassionate care begins with understanding each resident as an individual, including their preferences, abilities, and personal routines.
Supporting Independence With Personalized Attention
Family involvement is an important part of our approach to care. Regular communication helps loved ones remain informed about changes in health, daily functioning, and support needs.
Our Promise is to love and care for your family as we do our own.
This commitment reflects our belief that attentive care should support the whole person, not simply address a diagnosis.
What If Parkinson’s Causes Cognitive Changes?
Some individuals living with Parkinson’s experience changes in memory, thinking, or behavior.
When cognitive challenges become significant, specialized memory care may be appropriate.
At The Kensington Sierra Madre, we offer three memory care neighborhoods designed for different needs:
- The Kensington Club: For new and current assisted living residents experiencing mild cognitive changes.
- Connections: For residents experiencing mid-stage memory loss.
- Haven: For residents experiencing later-stage memory loss.
Our community is also a Positive Approach to Care Designated Community, reflecting our commitment to person-centered dementia support.
Importantly, Parkinson’s disease does not automatically mean someone needs memory care. The appropriate level of support depends on each individual’s physical, cognitive, and emotional needs.
Our assisted living and memory care options allow us to discuss how care may adapt as circumstances change.
Learn more about Our Promise at The Kensington Sierra Madre.
FAQs: Tavapadon for Parkinson’s
No. Tavapadon helps manage movement symptoms associated with Parkinson’s disease. It has not been shown to cure the condition or prevent its progression. For some individuals, improved symptom control may make everyday activities easier.
Yes. Clinical trials evaluated tavapadon both as a standalone medication and alongside levodopa. A neurologist can determine whether combination treatment is appropriate based on symptoms, medical history, and current medications.
AbbVie announced that it expected Juvmo to become available by prescription in the United States during October 2026. Actual pharmacy availability and insurance coverage may vary. Families should contact their prescribing clinician, pharmacist, or insurance provider for the latest information.
Looking Ahead: New Parkinson’s Treatments and Personalized Care
The FDA approval of tavapadon represents encouraging progress for individuals living with Parkinson’s disease.
While new medications may offer better symptom control, the right treatment plan depends on individual needs, medical guidance, and ongoing support.
At The Kensington Sierra Madre, we understand that families want more than assistance with daily tasks. You want your loved one to feel respected, comfortable, connected, and cared for.
Whether you’re exploring senior living for the first time or considering additional support as Parkinson’s progresses, we welcome the opportunity to learn about your family.
Connect With Our Kensington Family
Schedule a private tour or contact our team to explore personalized Parkinson’s support at The Kensington Sierra Madre.
This article is intended for educational purposes and does not replace professional medical advice. Always consult your loved one’s neurologist or prescribing clinician before making changes to Parkinson’s treatment.